Cat. No. 2145
Biological ActivityDimeric version of R18 peptide (Cat. No. 2144) that binds to 14.3.3 proteins with high affinity. Competitively inhibits 14.3.3-ligand interactions; blocks the ability of 14.3.3 to bind to target proteins such as Raf-1, Bad, ASK1 and exoenzyme S. Induces apoptosis when expressed in COS-7 and various cancer cells.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Hermeking (2003) The 14.3.3 cancer connection. Nature Rev.Cancer 3 931.
Masters et al (2002) Survival-promoting functions of 14.3.3 proteins. Biochem.Soc.Transactions 30 360.
Masters and Fu (2001) 14.3.3 proteins mediate an essential anti-apoptotic signal. J.Biol.Chem. 276 45193. PMID: 11577088.
If you know of a relevant reference for Difopein please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Difopein from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Difopein, supplier, High, affinity, inhibitors, inhibits, 1433, proteins, induces, apoptosis, 14-3-3, 14.3.3, Tocris Bioscience, 14.3.3 Protein Inhibitor products
Find multiple products by catalog number
June 14 - 17, 2017
Boston, MA, USA